Morphine activates neuroinflammation in a manner parallel to endotoxin

Xiaohui Wang1, Lisa C Loram, Khara Ramos

  • 1Department of Chemistry and Biochemistry, Center for Neuroscience, and Biofrontiers Institute, University of Colorado at Boulder, Boulder, CO 80309, USA.

Insights

Morphine triggers neuroinflammation through Toll-like receptor 4 (TLR4) and myeloid differentiation protein 2 (MD-2), not opioid receptors. Targeting this complex enhances pain relief and reduces inflammation, improving opioid efficacy.

Area of Science:

  • Neuroscience
  • Immunology
  • Pharmacology

Background:

  • Opioids can cause neuroinflammation in the central nervous system (CNS), which reduces their pain-relieving effects and causes side effects.
  • The mechanism behind opioid-induced neuroinflammation has been unclear, with the assumption that it involves traditional opioid receptors.

Purpose of the Study:

  • To investigate the mechanism by which morphine induces neuroinflammation.
  • To determine if opioid-induced neuroinflammation involves classic opioid receptors or other pathways.
  • To explore the potential of targeting novel pathways to improve opioid therapy.

Main Methods:

  • Morphine's interaction with Toll-like receptor 4 (TLR4) and its accessory protein myeloid differentiation protein 2 (MD-2) was examined.
  • Small-molecule inhibitors, RNA interference, and genetic knockout models were used to validate the TLR4/MD-2 complex.
  • The effect of disrupting the TLR4/MD-2 association on morphine analgesia and inflammation was assessed in vitro and in vivo.

Main Results:

  • Morphine activates neuroinflammation by binding to MD-2, leading to TLR4 oligomerization and proinflammation, independent of classic opioid receptors.
  • The TLR4/MD-2 complex was validated as a target for modulating morphine's effects.
  • Inhibition of the TLR4/MD-2 complex enhanced morphine analgesia in vivo and prevented morphine-induced inflammation in vitro.

Conclusions:

  • Morphine-induced neuroinflammation is mediated by the innate immune receptor TLR4/MD-2 complex, not by classic opioid receptors.
  • Targeting the TLR4/MD-2 complex offers a novel strategy to improve the clinical effectiveness of opioids by enhancing analgesia and mitigating adverse inflammatory responses.

Related Concept Videos

Opioid Receptors: Overview01:22

Opioid Receptors: Overview

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2, D-Pen5]-enkephalin or DPDPE for...
Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
Nociception01:44

Nociception

Nociception—the ability to feel pain—is essential for an organism’s survival and overall well-being. Noxious stimuli such as piercing pain from a sharp object, heat from an open flame, or contact with corrosive chemicals are first detected by sensory receptors, called nociceptors, located on nerve endings. Nociceptors express ion channels that convert noxious stimuli into electrical signals. When these signals reach the brain via sensory neurons, they are perceived as pain. Thus, pain helps the...
Acute Inflammation III: Local and Systemic Effects01:25

Acute Inflammation III: Local and Systemic Effects

Acute inflammation produces a coordinated set of local and systemic changes that limit injury, eliminate pathogens, and initiate repair. These responses arise within minutes of infection, trauma, or chemical insult and are driven by vascular alterations and leukocyte-derived mediators. When the stimulus resolves, the reaction typically abates within days.Local EffectsAt the site of injury, arteriolar vasodilation increases blood flow, resulting in redness and warmth. Simultaneously, increased...